Carotid Stent Market Size, Share, Industry Growth Report 2024-2031 | Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Medtronic Plc, Terumo Corporation, MicroPort Scientific, W. L. Gore & Associates

The carotid stent market was valued at approximately USD 336 million in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 7.20% during the forecast period from 2024 to 2031.

The Carotid Stent Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/carotid-stent-market?sg

Carotid Stent Market Overview:

Carotid stents are medical devices inserted into the carotid arteries to help clear plaque buildup. These stents help reduce the risk of stroke by widening narrowed arteries, thereby ensuring consistent and uninterrupted blood flow to the brain.

North America dominates the global carotid stent market, driven by several key factors, including a large patient population, increasing prevalence of cardiovascular diseases, and the early adoption of advanced medical technologies. A sedentary lifestyle, which significantly contributes to cardiovascular conditions, obesity, and hypertension, is becoming increasingly common. According to the World Health Organization (WHO), approximately 60% to 85% of the global population leads a sedentary lifestyle.

In the United States alone, data from the Centers for Disease Control and Prevention (CDC) reveals that nearly 31 million adults aged over 50 are physically inactive. Furthermore, only 1 in 4 adults and 1 in 5 students meet the recommended guidelines for physical activity. Cardiovascular disease remains a leading cause of death in the U.S., with one person dying every 37 seconds due to heart-related conditions, according to the CDC.

To address these challenges, North American governments are investing in healthcare improvements aimed at reducing hospital admissions and promoting better health outcomes. Enhanced access to advanced technologies, top-tier healthcare infrastructure, and growing awareness around drug therapies and disease prevention are further supporting market growth in this region.

Carotid Stent Market: Shifting Industry Trends

Rising Demand for Minimally Invasive Procedures Driving Carotid Stent Market Growth
The growing preference for minimally invasive (MI) procedures is playing a significant role in the expansion of the global carotid stent market. These procedures are gaining popularity due to their ability to minimize physical trauma and reduce the risk of infections, resulting in faster and more comfortable patient recovery.

Minimally invasive techniques offer several advantages over traditional surgical methods, including lower treatment costs, reduced hospital stays, and quicker return to daily activities. In the context of cardiovascular care, MI procedures typically involve the use of fine instruments inserted through small incisions to access the affected area. Patients undergoing these treatments often experience less pain, minimal scarring, and shorter recovery periods.

Moreover, these techniques have proven effective in managing various medical conditions, offering both clinical and cosmetic benefits. The increasing adoption of such procedures by healthcare professionals is not only improving treatment outcomes but also contributing to the rising demand for carotid stents, thus fueling market growth.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/carotid-stent-market?sg

Strategic Key Players Driving the Carotid Stent Market Forward: Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Medtronic Plc, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, BIOTRONIK SE & Co. KG, InspireMD, and Impulse Dynamics, Shanghai Hengfei Biological Technology Co., Ltd., Beijing Bomais Technology Development, Shanghai Zhenyu Biological Technology Co., Ltd, Shanghai Haoran Biotechnology Co., Ltd.

Research Methodology:

The global Carotid Stent Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Carotid Stent Market:

By Material (Metals, Other stents)

By Type (Self-Expanding Stents, Balloon-Expandable Stents)

By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers)

By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Industry Recent Developments:

✅ Boston Scientific acquires Silk Road Medical (~US $1.16 billion)
In June 2024, Boston Scientific announced it would acquire Silk Road Medical known for its ENROUTE Transcarotid Artery Revascularization (TCAR) stent system for $27.50/share, representing a 27% premium (~US $1.16 billion enterprise value)

✅ Medtronic - exclusive U.S. distribution for Contego Medical
In January 2025, Medtronic entered an exclusive U.S. distribution agreement with Contego Medical, which includes Contego's Neuroguard IEP carotid stent system alongside thrombectomy and peripheral vascular devices

Regional Analysis for Carotid Stent Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Carotid Stent Market Research Industry:

➠ Who leads the Carotid Stent industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Carotid Stent market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Carotid Stent market growth?

➠ What are the dominant sales and distribution strategies in the Carotid Stent industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.